Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canopy Growth Corp T.WEED

Alternate Symbol(s):  T.WEED.DB | CGC

Canopy Growth Corporation is a cannabis and consumer packaged goods (CPG) company. The Company delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space. Its CPG portfolio includes gourmet wellness products by Martha Stewart CBD, and vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution, and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a diverse range of cannabis, hemp, and cannabis products in Canada. Its Rest-of-world cannabis segment includes the production, distribution, and sale of a diverse range of cannabis and hemp products internationally. Its Storz & Bickel segment includes the production, distribution, and sale of vaporizers.


TSX:WEED - Post by User

Bullboard Posts
Post by aebestaceyon Apr 07, 2018 3:07pm
243 Views
Post# 27847892

Some Update from Past Week

Some Update from Past Week

Cannabis stocks declined sharply, falling for the fourth consecutive week. The Barron's cover story on Canadian LPs influenced the negativity, though the market bounced sharply on Wednesday.

The chill of the Sessions Memo persists, with the Bank of Springfield, the main bank for the Illinois cannabis industry, announcing it will stop serving the industry as of May 21. Connecticut’s House Appropriations Committee approved a bill for cannabis legalization, potentially leading to a vote later this year.

The Barron's cover story discussing the potential for excess supply in Canada and overly high valuations sparked heavy selling of LPs.

A few (unelected) Canadian Senators from the Conservative party continue to campaign against C-45, including traveling to Washington, D.C. to meet with Jeff Sessions.

ACBFF will become a preferred supplier to Pharmasave, a leading Canadian independent pharmacy, through CanniMed once Health Canada rules change

CNNRF reported its Q4, with sales exceeding C$1 million but a loss from operations of C$4.5 million

CVSI continued to pay down its convertible debt, with the balance at now just $225K

GBLX announced progress on its relationship with the University of Seville to develop cannabinoid-based nanoparticles for sustained relief from neuropathic pain

GRWG announced a proprietary nutrients and additives effort with Alliance Biologics

MEDFF announced its third brand for adult-use, AltaVie, targeting the premium health and wellness market

MPXEF reported an increase in Arizona sales in its Q4 ending 3/31 to C$5.2 million

NXTTF announced a large-scale observational study for cannabis use to treat anxiety. It also announced an LOI to acquire a Licensed Dealer application and reported March sales of C$1.24 million with strong patient acquisition on its NamasteMD Platform.

SLTK reported its 10-K, with sales falling 17% in Q4

SRNA filed its 10-K, with sales growth at 47% and net bookings growing 26% from Q3

TWMJF added LiveWell as a partner for Canopy Rivers and for Tweed Main Street.

 

Outlook

The cannabis sector is seeing improving quality due to new entrants and some of the older names executing. Valuations generally remain cautionary, and fundamentals are questionable for most of the over 600 companies in the sector.

The market has been in bull mode since late October and remains healthy despite the "Sessions Storm" that hit on January 4th. There are some catalysts ahead, including progress in the Canadian legalization and in German MMJ as well as the roll-out of the California implementation and Massachusetts in July. The demise of the Cole Memo has left a big overhang in the U.S. market.

The big themes ahead are likely to be insight into the President's plans regarding the federal view on state-legal cannabis (especially in light of the Jeff Sessions Memo from January 4th), hopeful extension later this year of the Rohrabacher-Blumenauer Amendment in the House and the Leahy Amendment in the Senate (which are now set to sunset on September 30th) to insulate state-legal medical cannabis businesses from DOJ intervention, better clarity from the federal government for banks and cannabis research (both part of the proposed CARERS Act and other proposed legislation), DEA pushback towards the CBD from industrial hemp industry, the inclusion of a broader range of extracts in Health Canada's ACMPR program and its continued growth in patient enrollment, likely legalization in Canada, the rollout of MMJ in Denmark, Germany, Mexico and in Australia as well as continued advances in South America, progress with respect to the new legal cannabis implementations in CA and MA, and the new MMJ implementations in Arkansas, Florida, Maryland, Ohio, Pennsylvania and Texas, the implementation of the new medical program in California and the possible legalization via the legislatures in CT, NH, NJ, NM, and RI and implementation of potential commercial programs in ME and VT.

Here are some of the most interesting stories:

$25 Million Fund Targets Canadian Cannabis Opportunities Beyond Cultivation

48North is Creating a Health and Wellness Cannabis Brand for Women

California Cannabis Licenses Now Represent 34.5% of All U.S. Licenses Issued

Canadian Cannabis Producer Execs Make Substantial Stock Purchases

Cannabis CRM Baker Opens Third Office as Customer Count Grows to 1000

Harvest One Debt-Free with Cash Balance at $80 Million after Debt Conversions

MJardin Launches GrowForce as Canadian Cannabis Facility Owner

MPX Arizona Operations Post Record $4 Million Sales in March

The Future of Cannabis Health Lies in Personalization

Tilray Unveils High Park Subsidiary in Advance of Canada’s Cannabis Legalization


Bullboard Posts